Scott Kathleen D. sold SPRY
August 21, 2025 · Form 4 insider transaction
Scott Kathleen D. sold 12,500 shares of ARS Pharmaceuticals, Inc. at $15.00 per share, a transaction worth $187.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
12,500
Price
$15.00
Total value
$187.5K
InsiderScott Kathleen D.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 21, 2025
Filing dateAugust 22, 2025
Shares owned after10,042
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on May 22, 2025.